Expression of PPARγ (peroxisome proliferator-activated receptor γ) is increased in breast cancer cell lines and primary breast tumors, and correlates with an acidic intracellular pH and it was suggested that judicious use of PPARγ ligands at low doses could have significant anti-cancer effects in combination with chemotherapy [44]. Here, PPARG is linked to cancer.